TELZOX TRIO (Telmisartan (40mg) + Amlodipine (5mg) + Hydrochlorothiazide (12.5mg))

Telzox Trio Tablet is a synergistic formulation designed to manage hypertension, particularly when monotherapy does not yield adequate results. This combination therapy effectively lowers elevated blood pressure, thereby decreasing the risk of serious cardiovascular events such as heart attacks and strokes. Patients are advised to administer the medication with or without food, adhering to the prescribed dosage based on individual health status and response to the therapy. Consistency is key; it is recommended to take the tablet at the same time daily. Continuing the medication is crucial, even if one feels well, as hypertension often presents without noticeable symptoms. Discontinuation may elevate the risk of heart-related complications. The formulation includes a diuretic component, which increases urination; to avoid nighttime disturbances, it is best to refrain from taking the tablet within four hours of bedtime. Regular intake can maximize therapeutic benefits. Common adverse effects may include headache, dizziness, fatigue, altered taste sensation, flu-like symptoms, gastrointestinal disturbances such as diarrhea, and sinus infections. If side effects become bothersome or persist, it is important to consult a healthcare provider. Adequate hydration is recommended to mitigate symptoms like muscle weakness and dry mouth. Prior to initiation, individuals should inform their physician of any existing kidney or liver conditions, as well as other medications being taken, especially those for hypertension or cardiac issues. Regular monitoring of blood pressure, kidney function, electrolyte levels, and blood glucose is advisable to ensure the medication’s safety and efficacy.